CEO of SFL invited to speak about European Orphan and Advanced Therapy Medicinal Products Regulations at GPKOL, South Korea
Shayesteh Fürst-Ladani, CEO of SFL, has been invited to give a key note speech at GPKOL (Global Pharma Key Opinion Leader) about European regulatory affairs with special focus on Orphan and Advanced Therapy Medicinal Products. GPKOL will take place during Bio Korea on 13 April 2017 in COEX Center in Seoul, South Korea. In her speech, Shayesteh will give an overview of the current as well as upcoming changes to both Regulations. Shayesteh will also attend Bio Korea and discuss opportunities for pharma and medtech companies interested in expansion from the Asia-Pacific region to Europe (EU and/or Switzerland).
Shayesteh has an extensive track record in negotiating company interests with different regulatory bodies and trade associations at a senior level. Her impressive contributions include organizing and chairing the RDAF (Rare Disease Action Forum) and international Medtech & Pharma Platform.
Please contact us to arrange a meeting with Shayesteh.